U.S. pharma huge copyright scrapped two experimental weight loss capsules final calendar year—a after-every day capsule, lotiglipron, on account of elevated liver enzymes and also a twice-each day pill, danuglipron, resulting from solid Negative effects—but CEO Albert Bourla has repo